Efudix Cream for Sun-Damaged and Superficial Skin

Efudix cream is a prescription skin treatment containing fluorouracil, also called 5-fluorouracil or 5-FU. It is commonly prescribed for actinic keratoses caused by sun damage and, in selected cases, superficial basal cell carcinoma, with the treatment response monitored by a clinician.

What Is Efudix Cream?

Efudix cream is a prescription medicine applied to the skin. Its active ingredient is fluorouracil, sometimes called 5-fluorouracil or 5-FU. Fluorouracil interferes with the growth of cells that divide quickly. In dermatology, this makes it useful for treating certain abnormal cells within sun-damaged skin.

It is most often used for actinic keratoses, which are rough, scaly areas of skin linked to long-term ultraviolet exposure. These lesions are common on the face, scalp, ears, forearms and backs of the hands. Efudix may also be considered for particular cases of superficial basal cell carcinoma when a dermatologist judges topical treatment to be appropriate.

This treatment is not a general moisturiser, cosmetic cream or routine remedy for unexplained rashes. A clinician should identify the lesion before treatment and explain where, how often and for how long the cream should be applied. Instructions can differ according to the diagnosis, body site, size of the treatment field and the individual’s skin response.

Why It Causes a Visible Skin Reaction

Efudix cream is designed to affect abnormal and damaged cells more than healthy surrounding skin. As the medicine works, treated areas commonly become red and inflamed. They may then feel tender, dry or itchy and can develop scaling, crusting, erosion or small areas of weeping.

Although the appearance can be uncomfortable, this reaction is often anticipated and does not necessarily mean the treatment is harming healthy skin. The degree of reaction varies considerably. Areas with more sun damage may react more strongly than areas with less damage, and facial skin may become more inflamed than skin in other locations.

The prescribing clinician should explain what level of reaction is expected and when to make contact. Patients should not extend treatment, apply a larger amount or treat additional areas to make the reaction occur faster. Equally, they should not stop treatment solely because mild-to-moderate redness develops unless their clinician has advised this approach.

Conditions Efudix May Be Used to Treat

The most common reason for prescribing Efudix is actinic keratosis. These are persistent, rough or sandpaper-like spots caused by cumulative sun exposure. While many remain stable, some actinic keratoses can develop into squamous cell carcinoma over time, so assessment and appropriate treatment are important.

Efudix can treat visible actinic keratoses and may address some abnormal cells across a broader area of sun-damaged skin, sometimes described as field treatment. Other suitable options may include freezing treatment, curettage, photodynamic therapy or other topical medicines. The most appropriate method depends on the number, location, thickness and clinical appearance of lesions.

In selected circumstances, fluorouracil cream may be used for superficial basal cell carcinoma. This is different from deeper or more aggressive forms of skin cancer, which often need surgical or other specialist treatment. A suspicious lesion should be professionally assessed, and people can learn more about skin cancer and the importance of timely evaluation.

How Efudix Cream Is Usually Applied

Efudix should be used exactly as prescribed. Before application, the skin is usually washed gently and dried. A small amount is generally applied in a thin layer to the specified treatment area, avoiding unaffected skin as far as possible. Hands should be washed carefully after application unless the hands themselves are being treated.

The cream should not be used on the eyelids, inside the nose or mouth, on mucous membranes, or near the eyes unless a specialist has specifically directed otherwise. It should also be kept away from children and pets. Patients should avoid covering the area with a dressing unless their clinician recommends it, because covering can increase absorption and irritation.

Daily sun protection is particularly important while using Efudix and while the skin heals. Treated skin may be more sensitive to ultraviolet light. Protective clothing, a broad-brimmed hat when appropriate, shade and a suitable broad-spectrum sunscreen can help reduce further sun damage. A clinician or pharmacist can advise on gentle skincare products that are compatible with treatment.

• Use only the prescribed amount and treatment schedule.
• Do not apply to broken skin unless specifically instructed.
• Avoid waxing, abrasive scrubs and irritating cosmetics on the treatment area.
• Contact the prescriber before using other medicated creams on the same area.

Side Effects, Precautions and Healing

Local skin reactions are common with Efudix. Redness, burning, itching, dryness, pain, swelling, scaling, crusting and temporary changes in skin colour can occur. These effects usually develop gradually during treatment and may continue for a period after the last application before the skin begins to recover.

Healing is not always immediate. After the inflamed phase, new skin gradually forms, and the final appearance may take several weeks or longer to settle. A clinician may recommend a follow-up appointment to confirm that the treated lesions have responded and to check the rest of the skin for other changes.

Efudix is not suitable for everyone. It may be avoided during pregnancy, and people who are pregnant, planning pregnancy or breastfeeding should discuss the treatment with their doctor. Those with a known allergy to fluorouracil or cream ingredients, an inherited dihydropyrimidine dehydrogenase deficiency, or significant immune suppression should make sure their prescriber knows their medical history and medicines.

Rarely, a severe local reaction or broader symptoms may occur. Severe pain, marked swelling, spreading rash, fever, significant eye exposure or symptoms that feel out of proportion to the expected skin response need prompt medical advice. The prescriber can determine whether treatment should be paused, adjusted or stopped.

Treatment Planning and Follow-Up

Efudix is one option within a wider plan for managing sun-damaged skin. A dermatologist may recommend it when there are multiple lesions or diffuse sun damage in one area. In other situations, a focused treatment such as freezing, biopsy, excision or another procedure may be more suitable, particularly if a lesion is raised, thick, bleeding, painful or diagnostically uncertain.

Before starting therapy, it is helpful for patients to confirm the exact area to treat, the intended schedule, expected reaction, skincare advice and how to contact the clinic if symptoms become difficult. Clear photographs taken before treatment may also help the clinical team compare progress, if they recommend this.

Regular skin examinations remain useful after treatment because fluorouracil does not remove the underlying tendency to develop sun-related skin changes. People with a history of significant sun exposure, actinic keratoses or skin cancer may benefit from an individualised surveillance plan. Appropriate dermatology assessment can help distinguish benign changes from lesions that need further investigation.

When to Seek Medical Care

Medical advice should be sought before using Efudix for any lesion that has not been diagnosed. A spot that is new, rapidly growing, darkly pigmented, irregular, repeatedly bleeding, ulcerated or not healing should be examined. These features do not always indicate cancer, but they should not be self-treated with leftover medication.

During treatment, patients should contact their prescribing clinician if they develop severe or rapidly worsening pain, extensive swelling, pus-like discharge, fever, a widespread rash, faintness, persistent vomiting, mouth sores or eye involvement. Accidental application in or very close to the eye should be addressed promptly according to medical advice.

It is also sensible to arrange review if the expected healing does not occur, if a treated area remains suspicious after recovery, or if new lesions appear. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support diagnosis and treatment planning for international patients with sun-damaged skin and skin lesions.

Frequently asked questions

What is Efudix cream used for?

Efudix cream is used mainly to treat actinic keratoses, which are sun-damaged, rough areas of skin. In selected cases, a specialist may also prescribe it for superficial basal cell carcinoma. The correct use depends on a confirmed diagnosis and an individual treatment plan.

Is redness normal when using Efudix cream?

Yes, redness and inflammation are common expected effects because fluorouracil acts on abnormal skin cells. Scaling, crusting, tenderness and temporary soreness can also occur. However, severe pain, marked swelling, fever or a reaction that concerns the patient should be discussed with the prescribing clinician.

How long does it take for skin to heal after Efudix?

The skin may continue to look inflamed for a time after the final application. Healing commonly develops gradually over several weeks, although the exact timeframe depends on the treatment area and the intensity of the reaction. A follow-up review can confirm whether healing is progressing as expected.

Can Efudix cream be used on the face?

Efudix may be prescribed for parts of the face, such as areas affected by actinic keratoses, but facial skin can react strongly. It should not be applied near the eyes, lips or inside the nose unless a specialist specifically directs this. Patients should follow the exact boundaries provided by their clinician.

Should Efudix cream be covered with a bandage?

A treated area should not usually be covered unless the prescriber has given specific instructions. Covering the skin can increase absorption and may worsen irritation. Patients should ask their clinician before using any dressing, plaster or occlusive product over the cream.

Can Efudix prevent future actinic keratoses?

Efudix can treat existing abnormal cells in the prescribed area, but it does not remove future risk from ultraviolet exposure. Ongoing sun protection and regular skin checks remain important. New or changing spots should be assessed by a qualified clinician.

References

• National Health Service
• British Association of Dermatologists
• American Academy of Dermatology
• National Cancer Institute
• Medicines and Healthcare products Regulatory Agency

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.